Current HIV News

 

Higher CD4 cell counts associated with lower rate of non-HIV-related diseases in patients taking antiretrovirals (April 25, 2008)

 

Clinical monitoring as effective as CD4 count and viral load for deciding when to switch to second-line ART in poor countries (April 25, 2008)

 

Benefit of starting HIV treatment early outweighs the risk of toxicities, SMART study shows (Apr 14, 2008)

 

SMART study reaffirms that HIV replication is harmful, even at CD4 counts above 350 (Apr 14, 2008)

 

Even Failing Treatment Reduces HIV in the Brain (Apr 2, 2008)

 

Lower-Dose Zerit May Improve Some Side Effects (Mar 26, 2008)

 

Genetic Variations Might Be Causing Mutations to HIV, Making It Less Potent, Study Says (Mar 25, 2008)

 

Ban on travelers with HIV into U.S. reviewed: Congress set to debate heavily criticized policy (Mar 26, 2008)

 

FDA update on Prezista (darunavir) “Information for Healthcare Professionals” (Mar 21, 2008)

 

FDA 101: Medication Errors (Mar 10, 2008)

 

Decreasing undiagnosed HIV infection helped reduce rate of HIV transmission in US (Mar 12, 2008)

 

Vaccination for pneumococcal pneumonia effective in HIV-positive men (Mar 11, 2008)

 

Fish Oil and Fenofibrate an Effective Combo for High Triglycerides (Mar 11, 2008)

 

Test for Abacavir Hypersensitivity Works in Black and White Patients(Mar 11, 2008)

 

Repeatedly HIV-negative patients with very advanced HIV disease: only 16 cases ever reported (Mar 10, 2008)

 

Genetically Reprogrammed Cells Could Battle HIV  (Mar 7, 2008)

 

Neuropathy Pain Patch Fails Test  (Mar 6, 2008)

 

Faith-Based Organizations Express Support for Needle-Exchange Programs (Mar 5, 2008)

 

Microbicides 2008: Will adherence issues affect all the first-generation trials? (Mar 3, 2008)

 

Microbicides 2008: Microbicides might benefit men more than women (Mar 1, 2008)

 

HIV Treatment Increases Survival, Not Heart Attack Risk (Feb 29, 2008)

 

New 600 mg Darunavir (Prezista) Formulation Allows for Fewer Pills per Dose (Feb 29, 2008)

 

New Approach Stops HIV At Earliest Stage Of Infection  (Feb 28, 2008)

 

Microbicides 2008: the second generation is on its way (Feb 28, 2008)

 

Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection (Feb 28, 2008)

 

VIDEO: Condom-Free Sex? Controversial Swiss Declaration (Feb 12, 2008)

Alone in a City’s AIDS Battle, Hoping for Backup (May 28, 2007)

GeoVax Vaccine Only 5th AIDS Vaccine Moving To Phase 2 Human Trials (Feb 26, 2008)

 

New Prezista 600 mg Tablet Approved (Feb 26, 2008)

 

Microbicides 2008: Accurate adherence reporting essential for microbicide trials (Feb 26, 2008)

 

Microbicides 2008: First hint of efficacy in rectal microbicide trial, thanks to new biopsy assay (Feb 25, 2008)

 

HIV persists in gut CD4 cells even in the presence of effective therapy Feb 25, 2008)

 

Drug Use Linked to Infection With Resistant Virus (Feb 21, 2008)

 

Study Links Zerit and Retrovir With Diabetes Risk (Feb 21, 2008

 

Dipstick Kidney Test Less Accurate in HIV (Feb 20, 2008)

 

UNAIDS & WHO 'Correct' Swiss on Unprotected Sex (Feb 1, 2008)

 

Politics and Policy | FDA To Require Vaginal Contraceptives Containing Nonoxynol-9 To Include Warning Label That Products Do Not Protect Against STIs, Including HIV (Dec 19, 2007)

 

Tests of Drug to Block H.I.V. Infection Are Halted Over Safety (Feb 1, 2007)

 

Microbicide Trials Halted in Africa, India Because of Possible Increased Risk of HIV Transmission (Feb 1, 2007)

 

Follow HIV testing guidelines to avoid false positive diagnosis (Feb 22, 2008)

 

GSK To Reduce Cost of 14 Antiretrovirals Sold in Developing Nations (Feb 20, 2008)

 

CROI: Once-daily Lopinavir/ritonavir (Kaletra) and Nevirapine (Viramune) Appear as Effective as Twice-daily (Feb 19, 2008)

 

GSK cuts the price of one of its most popular nukes, Ziagen (abacavir) ,by 31% for developing countries  (Feb 20, 2008)

 

CROI: Untreated HIV-positive individuals have a higher risk of death even at CD4 counts over 350 (Feb 7, 2008)

 

CROI: Herpes virus suppression with valaciclovir lowers viral load in HIV positive women: could work for gay men too (Feb 7, 2008)

 

CROI: Could earlier ART reduce risk of death from non-AIDS related illnesses in people with HIV? (Feb 6, 2008)

 

Controversy Over Swiss Statement on Safe Sex Without Condoms (Feb 2, 2008)

 

Swiss experts say individuals with undetectable viral load and no STI cannot transmit HIV during sex (Jan 30, 2007)

 

Factors affecting HIV therapy choice in women have changed  (Jan 23, 2008)

 

Emergence of Multidrug-Resistant, Community-Associated, Methicillin-Resistant Staphylococcus aureus Clone USA300 in Men Who Have Sex with Men

(from Annals of Internal Medicine Feb 2008 issue)

 

The Insure Thing (article about HIV positive young adults getting insurance in the Jan 2008 issue of POZ magazine)

 

FDA Approves INtELENCE(tM) (etravirine) for HIV Combination therapy; - INtELENCE is the first NNRtI to show antiviral activity in patients with NNRtI-resistant virus (Jan 22, 2008)

 

Groups Respond to Research That Links Drug-Resistant MRSA Strain to MSM Communities in Boston, San Francisco (Jan 22, 2008)

 

Atazanavir (Reyataz) Label Changes Cover Drug Interactions, Kidney Impairment (Jan 18, 2008)

 

New multi-drug resistant MRSA strain disproportionately affecting gay, HIV-positive men (Jan 15, 2008)

 

Continuing anti-HIV therapy reduces the risk of AIDS-defining events in patients with uncontrolled viral replication and severe immune suppression (Jan 11, 2008)

 

More Heart and Kidney Problems in Treated African Americans (Jan 10, 2008)

 

Most gays ruled out as organ donors: Health Canada ban goes too far to guard against HIV, doctors say (Jan 09, 2008) 

 

Updated guide shows which countries restrict entry and residence for people with HIV (Jan 7, 2008)

 

New York City's Death Rate Reaches Record Low in 2006 in Part Because of Decreased AIDS-Related Deaths (Jan 10, 2008)

 

Spanish find low prevalence of peripheral arterial disease in HIV-positive patients with heart disease risks (Jan 9, 2008)

 

High prevalence of asymptomatic heart disease in HIV-positive patients (Jan 9, 2008)

 

HIV/AIDS Experts, Doctors Voice Concerns About Health Problems Seen Among Long-Term HIV/AIDS Survivors (Jan 8, 2008)

 

HIV-Positive People With Depression More Likely to Follow Treatment Regimens When Taking SSRIs, Study Finds (Jan 8, 2008)

 

Book Examines Experiences of Children With HIV/AIDS, Addresses Treatment, Care, Support Issues (Jan 8, 2008)

 

AIDS patients face downside of living longer New York Times (Jan 6, 2008)

 

Injection drug use, low baseline CD4 counts continue to predict poorer HAART response after six years (Jan 2, 2008)

 

HIV Rates Up Among NY Gays Under 30  (Jan 1, 2008)

 

HIV-Infected Adults With a CD4 Cell Count Greater Than 500 Cells/mm3 on Long-Term HAART Reach Same Mortality Rates as the General Population – (Dec 27, 2007)
 

Darunavir Full Approval & For Naives: Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration - (Dec 21, 2007) 

 

Ingredient in human semen may enhance HIV infection (Dec 13, 2007)

 

Dietary Cod Protein Improves Insulin Sensitivity in Insulin-Resistant Men and Women (Nov 26, 2007)

 

Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV  (Nov 26, 2007)

 

AIDS Cases Drop, but Bad Data to Blame (Nov 20, 2007) 

 

Study shows how some AIDS vaccines may harm  (Nov 16, 2007)

 

Reuters AlertNet: Study shows how some AIDS vaccines may harm (Nov 15, 2007)

 

Lin, et al study: Recombinant adeno-associated virus vectors induce functionally impaired transgene product–specific CD8⁺ T cells in mice (Nov 15, 2007)

 

AASLD: Tibotec HCV Protease Inhibitor  (Nov 9, 2007)

 

Seattle Post-Intelligencer Examines Reactions of People Who Participated in Merck's Canceled HIV Vaccine Trial (Nov 9, 2007)

 

 Former Chair of Presidential Advisory Council on HIV/AIDS Hitt Dies (Nov 9, 2007)

 

HIV/AIDS Researchers Warn South African HIV Vaccine Trial Volunteers About Possible Increased Risk of HIV (Oct 25, 2007)

 

Catholic Church's Opposition to Condom Use Contributes to Spread of HIV in Latin America, UNAIDS Official Says (Oct 24, 2007)

 

Variation in HIV-1 set-point viral load: Epidemiological analysis and an evolutionary hypothesis (Oct 22, 2007)

 

Undetectable viral load is goal for all, together with earlier treatment, say new European treatment guidelines (Oct 25, 2007)

 

EACS: Cocaine Boosts Cardiovascular Risk in Spanish Patients With HIV  (Oct 25, 2007)

 

Scientists Track Progression of HIV to AIDS, Study Says (Oct 19, 2007)

 

Fosamprenavir: US approves once-daily dose with less ritonavir boosting (Oct 19, 2007)

 

FDA Approves Integrase Inhibitor, Raltegavir  (Oct 12, 2007)

 

Protein in spinal fluid can be a marker of HIV dementia (Oct 9, 2007)

 

Archived HIV News

 

Seven pharma firms join forces to identify patients at risk of adverse events (Sep 28, 2007)

 

Intermittent ART Raises Risk for AIDS-Associated Malignancy (Sep 24, 2007)

 

T-20 increases tipranavir levels but does not increase risk of liver side-effects (Sep 12, 2007)

 

Caution Regarding Nelfinavir Use in Children and Pregnant Women (Sep 10, 2007)

 

ICAAC: No drug interactions found between TMC125 and ritonavir-boosted elvitegravir (Sep 21, 2007)

 

ICAAC: Maraviroc failures associated with shifts from R5-tropic to mixed or X4-tropic HIV (Sep 20, 2007)

 

 ICAAC: 48-week results show maraviroc still potent in highly treatment-experienced (Sep 20, 2007)

 

 ICAAC: Dual/mixed tropic virus speeds disease progression as much as tenfold increase in viral load (Sep 19, 2007)

 

Raltegravir Approval Expected in October (Sep 06, 2007)

Merck & Co's AIDS drug Isentress is backed by FDA panel (Sep 06, 2007)
 

Heavy Drinkers living with HIV have lower CD4 counts  (Aug 31 2007)

 

Abbott warns on risk of overdose with Kaletra liquid (Aug 15, 2007)

 

SelzentryTM (Maraviroc) Tablets, CCR5 Inhibitor, Approved by FDA (Jul 27, 2007)

 

IAS: Pendulum swinging towards early treatment as burden of pre-AIDS illness recognised (Jul 27, 2007)

 

IAS: Truvada more effective than Ziagen due to drop-outs related to abacavir hypersensitivity (Jul 26, 2007)

 

IAS: Roche admits long-standing low-level contamination of nelfinavir (Jul 26, 2007)

 

IAS: Screening for B*5701 reduces abacavir hypersensitivity incidence to zero (Jul 25, 2007)

 

International AIDS Conference To Begin in Australia; More Than 5,000 Researchers To Discuss HIV/AIDS Treatment, Prevention Advances (Jul 20, 2007)

A Genetic Knack for Tackling HIV  (Jul 20 2007)

 

9th Intl Wrkshp on Adverse Drug Reactions and Lipo:

Effects of 4 weeks of atazanavir, lopinavir/ritonavir, or placebo on endothelial function and insulin sensitivity in healthy men (Jul 20 2007)

 

9th Intl Wrkshp on Adverse Drug Reactions and Lipo:

Relationship of body composition, antiretroviral use, and HIV disease factors to endothelial dysfunction in HIV-infected subjects: lipoatrophy associated with endothelial dysfunction (Jul 20, 2007)

 

IAS: 'HIV eradication now possible'  (Jul 20, 2007)

 

PFIZER RECEIVES APPROVABLE LETTER FROM FDA FOR MARAVIROC  (Jul 20, 2007)

 

Abbott Submits E.U. and U.S. Regulatory Filings for New Lower-Strength Kaletra and Aluvia (lopinavir/ritonavir) Tablet Suitable for Pediatric Use in HIV/AIDS  (Jul 20, 2007)

 

9th Intl Wrkshp on Adverse Drug Reactions and Lipo:

Lack of evidence of Metabolic Abnormalities and Mitochondrial Toxicity with Enfuvertide: a double-blind, placebo-controlled, cross-over study with random sequence assignation in healthy adult volunteers  (Jul 20, 2007)

 

9th Intl Wrkshp on Adverse Drug Reactions and Lipo: HIV, ART & Endothelial Dysfunction  (Jul 20, 2007)

 

The pre-IAS 2007 themed issue of The Lancet is available online (Jul 9, 2007)